Argonne National Laboratory

Collaborative AI effort unraveling SARS-CoV-2 mysteries wins prestigious Gordon Bell Special Prize

19-Nov-2020 4:05 PM EST, by Argonne National Laboratory

The Association for Computing Machinery (ACM) awarded its first ACM Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research to a multi-institution research team that included the U.S. Department of Energy’s (DOE) Argonne National Laboratory.

The team was singled out for its work, ​AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics,” which shines light how the SARS-CoV-2 virus infiltrates the human immune system, setting off a viral chain reaction throughout the body. The award was announced Nov. 19 at SC20, the International Conference for High Performance Computing, Networking, Storage, and Analysis, held virtually this year. 

We are excited to have won this prestigious award,” said Arvind Ramanathan, an Argonne computational biologist and co-principal investigator on the project. ​The whole point is to push the boundaries of what we can do with AI. The ability to scale such a huge set of simulations and use AI to drive some factors was key to this work.”

Supporting a large collaboration of research organizations and scientific disciplines, Argonne exploring the use of artificial intelligence and high-performance computing resources to study, in great detail, the complex dynamics of the spike protein, one of the key proteins in the SARS-CoV-2 virus. The research was supported in part by the the DOE’s National Virtual Biotechnology Laboratory with funding from the Coronavirus CARES Act.

The team, comprised of nearly 30 researchers across 10 organizations, is trying to understand how that protein binds to and interacts with one of the first point of contacts with the human cell, the ACE2-receptor protein. That binding begins a cascade of events that eventually lets the viral and human cell membranes fuse, allowing the SARS-CoV-2 virus to enter and infect the host.

Proteins aren’t static, they have a wide range of motions that span multiple length- and timescales and it’s not always understood which motions are important, notes Arvind Ramanathan, an Argonne computational biologist and co-principal investigator on the project. To understand and simulate those actions requires a huge amount of data and computing resources.

Developing a reasonable simulation of the spike protein alone can create a huge system consisting of approximately 1.8 million atoms and simulations can consist of enormous datasets that tax the resources of even the largest supercomputers. In order to make that data more accessible for interpretation, the team developed a machine learning method that can summarize large volumes of data.

One of the key things that this method allowed us to do was to determine what was interesting, what was important, even those things that were not obvious to the human eye,” said Ramanathan. ​So, when you look deeper using the simulations, you start seeing significant changes in the protein structure, which told us something about how the spike protein opens up such that it can interact with the ACE2 receptor.”

As the size of the systems they were working on grew, the team faced challenges of scaling all of the data to run fluidly on today’s biggest and best supercomputing systems, as well as their key components.

Because many of the machine learning models they were training on these large simulations needed to be efficiently scaled for use on supercomputers, they partnered with NVIDIA, a leader in GPU and artificial intelligence design, to effectively run the models on Summit, at the DOE’s Oak Ridge National Laboratory. The team also utilized many of the top U.S. supercomputers, including Theta at Argonne; Frontera/Longhorn at Texas Advanced Computing Center; Comet at San Diego Supercomputing Center; and Lassen at DOE’s Lawrence Livermore National Laboratory, to uncover alternate ways to handle the deluge of data.

Given the complexity of the data, trying to understand the ACE2 receptor-spike interaction seemed almost impossible at this scale,” Ramanathan confided. ​One of the things that we clearly showed was that we could actuate a sampling of these dynamical configurations, pushing the idea that we could use AI to bridge these different scales.”

The data generated, so far, is providing new insights into how the stalk region of the spike protein changes its overall motions when it interacts with the ACE2 receptor, he said. Eventually, these kinds of insights derived from the highly conjoined combination of machine learning and simulation will help facilitate antibody or vaccine discoveries.

The team’s article, ​AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics,” will appear in the International Journal of High Performance Computing Applications, 2020

This research was supported by the Exascale Computing Project, a collaborative effort of the U.S. DOE Office of Science and the National Nuclear Security Administration, and the DOE’s National Virtual Biotechnology Laboratory with funding from the Coronavirus CARES Act. This work used resources, services, and support from the COVID-19 HPC Consortium.

Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation’s first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America’s scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy’s Office of Science.

The U.S. Department of Energy’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit https://​ener​gy​.gov/​s​c​ience.




Filters close

Showing results

110 of 4147
Newswise: COVID-19 Peer Hub combats vaccine avoidance amid pandemic
Released: 27-Nov-2020 8:05 AM EST
COVID-19 Peer Hub combats vaccine avoidance amid pandemic
University of South Australia

UniSA researchers are evaluating a new vaccination education initiative – the COVID-19 Peer Hub – to help immunisation and public health professionals to tackle the emerging dangers of vaccine hesitancy amid the pandemic.

Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction


Showing results

110 of 4147

close
0.90666